Hostname: page-component-6766d58669-fx4k7 Total loading time: 0 Render date: 2026-05-19T16:03:51.398Z Has data issue: false hasContentIssue false
  • English
  • Français

Demonstrating the influence of HTA: INAHTA member stories of HTA impact

Published online by Cambridge University Press:  05 November 2020

Sophie Söderholm Werkö ,
Tracy Merlin ,
Laurie Jean Lambert ,
Paul Fennessy ,
Ana Pérez Galán  and
Tara Schuller Open the ORCID record for Tara Schuller [Opens in a new window]
Sophie Söderholm Werkö
Affiliation:
Swedish Council on Health Technology Assessment and Assessment of Social Services, Stockholm, Sweden
Tracy Merlin
Affiliation:
Adelaide Health Technology Assessment, School of Public Health, University of Adelaide, Adelaide, South Australia, Australia
Laurie Jean Lambert
Affiliation:
Institut national d'excellence en santé et en services sociaux, Montreal, Québec, Canada
Paul Fennessy
Affiliation:
Victorian Department of Health & Human Services, Melbourne, Victoria, Australia
Ana Pérez Galán
Affiliation:
División Evaluación Sanitaria, Sanitaria, Uruguay
Tara Schuller*
Affiliation:
INAHTA Secretariat, c/o Institute of Health Economics, 1200, 10405 Jasper Avenue NW, Edmonton, Alberta, Canada
*
Author for correspondence: Tara Schuller, E-mail: tschuller@ihe.ca
Get access Rights & Permissions [Opens in a new window]

Abstract

A central function of health technology assessment (HTA) agencies is the production of HTA reports to support evidence-informed policy and decision making. HTA agencies are interested in understanding the mechanisms of HTA impact, which can be understood as the influence or impact of HTA report findings on decision making at various levels of the health system. The members of the International Network of Agencies for HTA (INAHTA) meet at their annual Congress where impact story sharing is one important activity. This paper summarizes four stories of HTA impact that were finalists for the David Hailey Award for Best Impact Story.

The methods to measure impact include: document review; claims analysis and review of reimbursement status; citation analysis; qualitative evaluation of stakeholders’ views; and review of media response. HTA agency staff also observed changes in government activities and priorities based on the HTA. Impact assessment can provide information to improve the HTA process, for example, the value of patient and clinician engagement in the HTA process to better define the assessment question and literature reviews in a more holistic and balanced way.

HTA reports produced by publicly funded HTA agencies are valued by health systems around the globe as they support decision making regarding the appropriate use, pricing, reimbursement, and disinvestment of health technologies. HTAs can also have a positive impact on information sharing between different levels of government and across stakeholder groups. These stories show how HTA can have a significant impact, irrespective of the health system and health technology being assessed.

Keywords

Technology assessmentBiomedicalDecision makingQuality assuranceHealthcareProgram evaluation

Information

Type
Article Commentary
Information
International Journal of Technology Assessment in Health Care , Volume 37 , Issue 1 , 2021 , e8
Copyright
Copyright © The Author(s), 2020. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

International Network of Agencies for Health Technology Assessment (INAHTA) [Internet] The influence of Health Technology Assessment: a conceptual paper; 2014 [cited 2020 May 19]; Available from: http://www.inahta.org/wp-content/uploads/2014/03/INAHTA_Conceptual-Paper_Influence-of-HTA1.pdf.Google Scholar
International Network of Agencies for Health Technology Assessment (INAHTA) [Internet] Published evidence on the influence of Health Technology Assessment; 2014 [cited 2020 May 19];. Available from: .Google Scholar
International Network of Agencies for Health Technology Assessment (INAHTA) [Internet] [cited 2020 May 20]; Available from: http://www.inahta.org.Google Scholar
International Network of Agencies for Health Technology Assessment (INAHTA) [Internet] Strategic plan 2017-2020 [cited 2020 May 19]; Available from: http://www.inahta.org/wp-content/uploads/2019/02/INAHTA-Strategic-Plan-2017-2020.pdf.Google Scholar
International Network of Agencies for Health Technology Assessment (INAHTA) [Internet] David Hailey Award for Best Impact Story [cited 2020 May 18]; Available from: http://www.inahta.org/hta-tools-resources/hta-impact-influence/#Story.Google Scholar
Medical Services Advisory Committee [Internet] What is MSAC? Australian Government Department of Health [cited 2020 Aug 7]. Available from: http://www.msac.gov.au/internet/msac/publishing.nsf/Content/factsheet-04.Google Scholar
Merlin, T, Newton, S, Hedayati, H, McCaffrey, N, Moss, J, Hiller, J. Vertebroplasty and kyphoplasty for the treatment of vertebral compression fracture. MSAC Reference 27 Assessment Report. Canberra, ACT: Commonwealth of Australia; 2005.Google Scholar
Doidge, J, Merlin, T, Liufu, Z, Tamblyn, D, Jia, L, Hiller, J. Review of Interim Funded Service: Vertebroplasty and new Review of Kyphoplasty. MSAC Application 27.1 Assessment Report. Canberra, ACT: Commonwealth of Australia; 2011.Google Scholar
Medical Services Advisory Committee [Internet] Public Summary Document. Application No. 1466 – Vertebroplasty for severely painful osteoporotic vertebral fractures of less than 6 weeks duration. March 2019 consideration [cited 2020 May 12]; Available from: http://www.msac.gov.au/internet/msac/publishing.nsf/Content/1466-Public.Google Scholar
Buchbinder, R, Osborne, RH, Ebeling, PR, Wark, JD, Mitchell, P, Wriedt, C, et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures. N Engl J Med. 2009;361:557–68.CrossRefGoogle ScholarPubMed
Kallmes, DF, Comstock, BA, Heagerty, PJ, Turner, JA, Wilson, DJ, Diamond, TH, et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures. N Engl J Med. 2009;361:569–79.CrossRefGoogle ScholarPubMed
Clark, W, Bird, P, Gonski, P, Diamond, TH, Smerdely, P, McNeil, HP, et al. Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet. 2016;388:1408–16.CrossRefGoogle ScholarPubMed
Firanescu, CE, de Vries, J, Lodder, P, Venmans, A, Schoemaker, MC, Smeet, AJ, et al. Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compression fractures (VERTOS IV): randomised sham controlled clinical trial. BMJ. 2018;361:k1551. doi:10.1136/bmj.k1551.CrossRefGoogle ScholarPubMed
Standing, H, Exley, C, Flynn, D, Hughes, J, Joyce, K, Lobban, T, et al. A qualitative study of decision-making about the implantation of cardioverter defibrillators and deactivation during end-of-life care. Health Serv Deliv Res. 2016;4.CrossRefGoogle Scholar
Allen, LA, Stevenson, LW, Grady, KL, Goldstein, NE, Matlock, DD, Arnold, RM, et al. Decision making in advanced heart failure: a scientific statement from the American Heart Association. Circulation. 2012;125:1928–52.CrossRefGoogle ScholarPubMed
Lewis, KB, Stacey, D, Matlock, DD. Making decisions about implantable cardioverter-defibrillators from implantation to end of life: an integrative review of patients’ perspectives. Patient. 2014;7:243–60. doi:10.1007/s40271-014-0055-2.CrossRefGoogle ScholarPubMed
Australian Health Ministers’ Advisory Council [Internet] National Health Genomics Policy Framework 2018-2021; 2017 [cited 2020 May 10]; Available from: https://www.coaghealthcouncil.gov.au/Portals/0/Genomics%20Framework%20WEB_1.PDF.Google Scholar
Australian Health Ministers’ Advisory Council [Internet] Supplemental information to the National Health Genomics Policy Framework 2018-2021; 2017 [cited 2020 May 11]; Available from: https://www.coaghealthcouncil.gov.au/Portals/0/Genomics%20Supplement%20WEB%203%20NOV.PDF.Google Scholar
Australian Health Ministers’ Advisory Council. Implementation plan: National Health Genomics Policy Framework Driving National Action 2018-2021; 2018 [cited 2020 May 10]; Available from: https://www.coaghealthcouncil.gov.au/Portals/0/Genomics%20Policy%20Framework%20Implementation.pdf.Google Scholar
Menicucci, TMG, Machado, JA. Judicialization of health policy in the definition of access to public goods: individual rights versus collective rights. Braz Political Sci Rev. 2010;5(SE). ISSN 1981-3821.Google Scholar
Jiménez, H. El derecho a la salud en las américas: reconocimiento constitucional y derechos afines; 1997 [cited 2020 Aug 10]; Available from: http://www.smu.org.uy/publicaciones/noticias/noticias91/saludas.htm.Google Scholar
Aleman, A, Perez Galan, A. Impact of health technology assessment in litigation concerning access to high-cost drugs. Int J of Technol Asses Health Care. 2017;33:411–4. Doi:10.1017/S0266462317000575CrossRefGoogle ScholarPubMed